FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Clears Ultromics EchoGo Amyloidosis Device

FDA clears an Ultromics 510(k) for the EchoGo Amyloidosis for detecting cardiac amyloidosis.

latest-news-card-1
Human Drugs

Sage Ending Dalzanemdor Development

Sage says it is ending dalzanemdor development in Huntingtons disease cognitive impairment following Phase 2 DIMENSION results that did not meet prima...

latest-news-card-1
Medical Devices

Draeger Atlan Recall is Class 1

FDA says the Draeger recall correction of its Atlan A350 and A350XL anesthesia workstations is Class 1.

latest-news-card-1
Medical Devices

Smiths Recalls Infusion Pump Battery Packs

Smiths Medical recalls (Class 1) its CADD-Solis Li-ion Rechargeable Battery Packs to update instructions for use due to a potential battery malfunctio...

latest-news-card-1
Federal Register

Fortesta Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Endos Fortesta (testosterone) gel was not withdrawn due to safety or effectiveness reasons.

latest-news-card-1
Medical Devices

Third-Party Review Guidance

FDA publishes a guidance with information on third-party review of 510(k)s and emergency use authorizations.

latest-news-card-1
Marketing

New DTC Major Statement Standards Become Effective

New FDA advertising standards require drug marketers to ensure their direct-to-consumer advertisements major statement is presented in a clear, conspi...

latest-news-card-1
Biologics

Preserve Covid-19 Vaccine Records: Senator

Republican Sen. Ron Johnson orders FDA, HHS, and CDC to preserve all records relating to Covid-19 vaccines, saying they will be subpoenaed if they are...

latest-news-card-1
Human Drugs

CDER Deputy Throckmorton Retiring in January

CDER deputy director for regulatory programs Doug Throckmorton announces his retirement after 27 years at the agency.

latest-news-card-1
Human Drugs

FDA Finds CGMP Violations in Originitalia Inspection

FDA warns Italys Originitalia about CGMP violations in its production of finished drugs.